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'Did you ever look at the stars?' he asked, pointing upwards. 
'Often and often,' answered Will. 
'And do you know what they are?' 
'I have fancied many things.' 
'They are worlds like ours,' said the young man. 'Some of them less; many of them a million times 
greater; and some of the least sparkles that you see are not only worlds, but whole clusters of worlds turning 
about each other in the midst of space. I do not know what there may be in any of them; perhaps the answer 
to all our difficulties or the cure of all our sufferings.' 
“Will O' the Mill” 1887 Robert Louis Stevenson  
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ABSTRACT 
Astrocytes are glial cells that express several specific transporters and channels 
with specialized functions to maintain water, ion and neurotransmitter 
concentrations in order to preserve normal neuronal function. Astrocytes express 
two catalytic isoforms of plasma membrane enzyme Sodium Potassium-ATPase 
(Na,K-ATPase), that are essential for several of astrocyte’s functions. In each 
cycle Na,K-ATPase actively transports 3 Na
+
 ions out of the cell and 2 K
+
 ions 
into the cell, using the energy of one ATP molecule. Na,K-ATPase establishes 
transmembrane Na
+
 gradient that allows for efficient Na
+
-coupled transport, 
including glutamate uptake. Na,K-ATPase is also responsible for active K
+
 
uptake from extracellular space and therefore maintenance of extracellular K
+ 
homeostasis. The overall goal of this thesis was to study the molecular and 
functional interactions between the Na,K-ATPase and other proteins responsible 
for astrocyte function. 
The water channel aquaporin 4 (AQP4) is abundantly expressed in astrocytes. 
Emerging evidence suggests that AQP4 facilitates extracellular K
+
 clearance by 
astrocytes and contributes to recovery of neuronal excitability. We found that 
AQP4 can assemble with its regulator metabotropic glutamate receptor 5 
(mGluR5) and with Na,K-ATPase. The AQP4 NH2-terminus was shown to 
interact with Na,K-ATPase catalytic α subunit and with mGluR5. Föster 
resonance energy transfer (FRET) studies in primary astrocytes derived from rat 
striatum showed that interaction occurs in intact cells. Thus AQP4/Na,K-
ATPase/mGluR5 can form a macromolecular complex in astrocytes, that may be 
of functional importance for the regulation of water and K
+
 homeostasis in the 
brain. 
Astrocytes express two isoforms of the Na,K-ATPase catalytic α subunit: the 
ubiquitous α1 and the α2, which in the brain is predominantly expressed in 
astrocytes. The α2 isoform has lower Na+ affinity than α1. We explored the 
relative roles of the α1 and α2 isoforms for the support of Na+-coupled glutamate 
uptake in primary astrocytes. We found that the α2 isoform contributes to a more 
efficient restoration of increases in intracellular sodium concentration ([Na
+
]i) 
evoked by the Na
+
-coupled glutamate uptake. Both α1 and α2 interacted 
molecularly with glutamate transporters via the 1
st
 intracellular loop, but the 
interaction with α2 appeared stronger. The study points to a specific role for α2 
in the handling of [Na
+
]i transients in astrocytes and suggests that α1 and α2 may 
differ with regard to capacity to interact with the glutamate transporters. 
Mutations in the Na,K-ATPase α2 subunit are associated with the neurological 
disease familial hemiplegic migraine type 2 (FHM2). In this study we 
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determined α1 and α2 abundance and glutamate uptake in primary cultures from 
heterozygous and homozygous α2 mutant mice carrying the human knock-in 
FHM2-mutation G301R. Both α2 abundance and glutamate uptake were 
significantly reduced in astrocytes expressing the mutant α2. The plasma 
membrane expression of mutant Venus-tagged α2 was also reduced in 
comparison to wild type α2. The results suggest that reduced capacity of 
astrocytes expressing α2 G301R mutant to take up glutamate, may lead to 
temporary increases in ambient glutamate concentration that, at least to some 
extent, may contribute to the symptoms in FHM2. 
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1 INTRODUCTION 
1.1 ASTROCYTES 
Brain function has long been attributed solely to the connectivity of neurons. 
However, new emerging evidence implicates glial cells in the majority of brain 
functions, including signal processing and output regulation. There are several 
types of CNS glia: oligodendrocytes – myelinating cells, microglia – immune 
defense cells and astrocytes – having diverse functions for neuronal support and 
recently NG2 glia was recognized as a CNS glia type - glial cell progenitors. 
Astrocytes express a large variety of transmembrane proteins, including 
metabotropic and ionotropic receptors, which allow them to sense neuronal 
activity and respond accordingly. In fact, astrocytes express almost the same set 
of receptors and ion channels as neurons, yet with K
+
 channels dominating over 
Na
+
 channels, preventing glial cells from generating action potentials. In 
different brain areas and even within the same brain area, the astrocyte 
population is heterogeneous both by morphology and astrocyte markers, as well 
as by expression of specialized plasma membrane (PM) proteins; probably to 
support the function of particular brain areas (Zhou and Kimelberg 2001; 
Matyash and Kettenmann 2010; Oberheim, Goldman et al. 2012).  
1.2 ASTROCYTE FUNCTION 
Astrocyte functions are numerous and diverse. The polarized morphology of 
astrocytes make them a key part in the blood-brain barrier, also being responsible 
for maintaining the homeostasis of the extracellular milieu, where they sense pH, 
ions, metabolites and other chemicals in the extracellular compartments and 
interstitial spaces (Nedergaard, Ransom et al. 2003; Kimelberg and Nedergaard 
2010). Astrocytes play an important role for K
+
 and neurotransmitter re-uptake 
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following neuronal activity, preventing neuronal excitotoxicity and 
neurodegeneration. Lately, astrocyte roles in modulating neuronal activity have 
been recognized. Astrocytes can modulate neurotransmission by releasing 
gliotransmitters into synaptic cleft, which include glutamate, ATP, D-Serine, 
GABA, and others (for review see Volterra and Meldolesi 2005; Angulo, Le 
Meur et al. 2008; Perea, Navarrete et al. 2009). One astrocyte may connect to 2 
million synapses, which is believed to contribute significantly to synchronized 
neuronal activity by mediating signals via astrocyte processes locally to 
synapses. Astrocyte leaflets, or as they are also called peripheral astrocyte 
processes, experience vast motility. Astrocyte coverage of synapses varies 
between brain regions and is temporally dependent on neuronal activity (for 
review see Bernardinelli, Muller et al. 2014). The coverage of the synapse may 
play a role in synaptic plasticity as well as synaptogenesis.  
In addition astrocytes have been shown to modulate local blood flow which is 
dependent on brain metabolism (Gordon, Choi et al. 2008). Also, astrocytes 
provide neurons with metabolic substrates via the proposed “glucose-lactate 
shuttle” process (for review see Magistretti 2006). Astrocytes can sense activity 
within the synapses and increase lactate production. This pathway starts with the 
uptake of neurotransmitter into astrocytes via the Na
+
-coupled transporter. The 
local rise of intracellular sodium concentration ([Na
+
]i) activates Na,K-ATPase – 
an ATP dependent enzyme. It has been proposed that the associated increase in 
energy demand of the astrocyte will enhance its anaerobic glycolysis and, as a 
result, more lactate will be released for the neighboring neurons. Signaling 
events that occur between the Na,K-ATPase activation and increased glucose 
uptake by astrocytes, remain to be understood. 
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1.3 ASTROCYTES IN DISEASE 
Several pathological conditions are associated with astrocyte dysfunction. For 
example, in mesial temporal lobe epilepsy, astrocyte K
+
 and water channels as 
well as glutamate transporter functions have been found to be altered, leading to 
overexcitation and seizures (for review see Seifert and Steinhauser 2013). Also, 
other pathologies are attributed to mutations in genes expressed in astrocytes. 
Mutations in the Na,K-ATPase α2 are associated with hemiplegic migraine; 
mutations in GFAP cause Alexander disease; and the mutated form of the 
antioxidant enzyme superoxide dismutase 1 (SOD1) leads to familial 
amyotrophic lateral sclerosis (ALS) (for review see Li, Messing et al. 2002; 
Nagai, Re et al. 2007; Bottger, Doganli et al. 2012). 
Astrocyte dysfunction is also associated with several neurodegenerative diseases, 
such as Alzheimer (AD), Parkinson, ALS and others (for review see 
Verkhratsky, Olabarria et al. 2010). Astrocytes are affected at a very early stage 
of neurodegenerative pathology, when neuronal connectivity starts to change. 
Atrophic changes, such as a reduction in the number of primary and secondary 
branches in astrocytes have been noticed early in disease development and may 
contribute to a disrupted metabolic neuron-astrocyte connection, excitotoxicity 
and neuronal death. 
1.4 ASTROCYTE MICRODOMAINS  
Astrocytes have an irregular shape with many processes extending from the cell 
soma and numerous endpoint leaflets (in humans more than 2 million, in rodents 
around 120 000), enabling one single astrocyte to have numerous connections 
with thousands of synapses, capillaries, arterioles and other glial cells. 
Astrocytes also provide connectivity between each other by gap junctions 
creating an astrocyte syncytium, allowing spreading of molecules as big as 1 
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kDa. For instance, Na
+
 and glucose can spread via the astrocyte syncytium over 
several hundred micrometers, which may trigger signaling and metabolic 
changes in connected cells (Bernardinelli, Magistretti et al. 2004; Rouach, 
Koulakoff et al. 2008). The syncytium can have local, anatomical restrictions of 
connectivity, only allowing for molecular spread within a certain area, such as in 
the somatosensory cortical barrels and in olfactory bulbs glomeruli (Houades, 
Koulakoff et al. 2008; Roux, Benchenane et al. 2011). Astrocytes have a 
localized area of influence, as noticed for protoplasmic astrocytes in the 
hippocampus, that occupy defined units, that do not overlap with neighboring 
astrocytes (Bushong, Martone et al. 2002). This may allow each single astrocyte 
to have local sensitivity and modulate activity in corresponding area. 
Modulations and influences in local and restricted areas are also achieved by the 
PM of any cell exhibiting a varying composition of microdomains, which serves 
particular cellular functions. Since astrocytes are polarized cells with diverse 
inter-cellular contacts, the targeting of proteins to a particular astrocytic unit as 
well as protein-protein co-assemblies, may be critical for generating functional 
microdomains. The extracellular space in the brain is also divided into 
microdomains of restricted volumes. As an example, the tripartite synapse, 
where a neuronal synapse is enveloped by astrocyte leaflets, allows for diffusion-
limited space restriction and neuron-astrocyte communication. The diffusion-
limited spaces allow little spillover of released ions and neurotransmitters, and 
thus efficient maintenance of homeostasis. 
1.5 ION AND WATER BALANCE IN THE BRAIN 
Ion and water homeostasis in the brain is of outmost importance to 
ensure normal neurological function. The narrow intracellular and extracellular 
spaces create diffusion-limited spaces for ions, neurotransmitters and 
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metabolites. The concentrations of these affect the function of pumps, ion 
exchangers, channels and other ion-coupled transports. A well-tuned water 
balance is one of the determinants of molecular concentrations, especially in 
diffusion-limited spaces. Extracellular and intracellular ion concentrations both 
influence resting membrane potential, which partially affects the direction of 
transport through channels and transporters. 
1.5.1 Extracellular potassium concentration 
One function of astrocytes is to maintain the extracellular water and ion milieu in 
order to preserve neuronal excitability. During neuronal activity, extracellular K
+
 
changes from basal values of around 3-4 mM up to 10 mM. However, in 
pathology, such as ischemia and migraine, this limit can be exceeded and 
extracellular K
+
 concentration can increase to around 60 mM. In physiologic 
conditions, K
+
 is returned to basal levels by local glial and neuronal uptake: 
passive uptake through channels such as NKCC1 and Kir4.1 and active uptake 
via the Na,K-ATPase enzyme. It is still debated which uptake mechanism that is 
most important for restoring extracellular K
+
 concentrations, as well as the 
temporal and spatial involvement of these mechanisms (Macaulay and Zeuthen 
2012). After K
+
 enters the astrocyte syncytium it is believed to move down the 
concentration gradient via gap junctions and eventually exit into the blood 
stream (for review see Kofuji and Newman 2004). Accompanying water 
facilitates K
+
 clearance, which has been supported by genetic knock-out studies 
of the major water channel in the brain – AQP4. Genetic knock-out of the AQP4 
channel shows slower recovery of extracellular K
+
 concentration (Amiry-
Moghaddam, Williamson et al. 2003; Binder, Yao et al. 2006; Strohschein, 
Huttmann et al. 2011). Increases in extracellular K
+
 concentrations have also 
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been shown to dynamically affect astrocyte AQP4 function by regulation of 
AQP4 water permeability (Song and Gunnarson 2012). 
1.5.2 Intracellular sodium concentration 
The astrocyte transmembrane Na
+
 gradient (around 130-140 mM extracellularly 
and 3-15 mM intracellularly) allows for a range of functions, including: Na
+
-
coupled transport of various molecules down the Na
+
 concentration gradient, 
which is essential for the membrane potential (MP) and recently has been 
suggested to be involved in astrocyte metabolic signaling; as well as clearance of 
extracellular K
+
 ions (for review see Kirischuk, Parpura et al. 2012). Studies 
have demonstrated that in astrocyte primary and secondary processes, a local rise 
in [Na
+
]i may occur, mainly resulting from glutamate Na
+
-coupled uptake 
(Langer and Rose 2009). Sodium signaling has also been proposed to pass 
through the astrocytic network via gap junctions, possibly affecting the function 
of neighboring astrocytes, transmitting signals for metabolic changes including 
glucose uptake and the production of lactate, - resulting in modulations of 
neuronal activity (Bernardinelli, Magistretti et al. 2004; Magistretti 2006; 
Langer, Stephan et al. 2012). 
Astrocyte [Na
+
]i fluctuations are due to work of several Na
+
 channels and 
transporters: Na,K-ATPase; NKCC1; glutamate transporters; GABA 
transporters; AMPARs; NMDARs; purinoreceptors; sodium/calcium exchanger 
(NCX); Sodium Hydrogen Exchanger (NHE); sodium/bicarbonate co-transporter 
NBC; monocarboxylate transporter (MCT1); glucose transporter (GLUT); 
mitochondrial sodium/calcium exchanger (NCLX), and others. The direction of 
the Na
+
 current is mostly dependent on the MP and the ligands concentrations. 
Sodium transporters and channels are tightly coupled; hence they can affect each 
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other’s function via their common Na+ ligand, regulating major functions of the 
cell. 
1.6 PROTEIN FUNCTIONAL DOMAINS 
Most cellular functions are defined by proteins functions. Protein complexes 
often include proteins that serve the same function in the cell, presumably 
because it is “energy and time efficient” for the cell. The close proximity of 
functionally coupled proteins often affects activity of the complex by 
conformational changes and influence on the local ligand gradients. It is a 
current opinion in cell biology, that functionally coupled proteins commonly 
form domains in the subcellular compartment with a particular function 
(Hartwell, Hopfield et al. 1999).  
Protein-protein interactions are often mediated via specific interaction domains, 
such as Src homology 2 and 3 (SH2 and SH3); phosphotyrosine-binding domain 
(PTB); PDZ domain; PH domain; and many others that recognize particular 
amino acid sequence on the partner protein (for review see Pawson and Nash 
2003). Scaffolding proteins and scaffold-associated proteins may mediate 
assembly of the network of functionally coupled protein complexes, and target 
them to a particular cellular domain. In astrocytes, the polarized targeting of 
proteins is largely unexplored, probably because the astrocyte specialized 
domains - for instance the perivascular or perisynaptic domains - are formed in 
the 3D structure of the brain. However, for several proteins of interest in this 
thesis some scaffolding proteins allowing for polarized expression were detected. 
For instance, the water channel AQP4 binds via its C-terminal SSV amino acid 
motif to a PDZ domain of α-syntrophin of the dystrophin protein complex, 
which targets AQP4 to the astrocyte perivascular endfeet (Amiry-Moghaddam, 
Xue et al. 2004; Bragg, Amiry-Moghaddam et al. 2006). Whilst the astrocyte 
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glutamate transporter GLAST C-terminus binds to the PDZ domain of the 
NHERF1 scaffolding protein, which probably allows the targeted expression in 
astrocyte (Lee, Rayfield et al. 2007). 
1.7 NA,K-ATPASE  
The key protein for Na
+
 and K
+
 homeostasis, as well as for the transmembrane 
ion gradients, is the Na,K-ATPase. Na,K-ATPase is the most energy consuming 
enzyme in the brain, consuming around 50 % of all the energy used by the brain 
(Ames 2000). In each cycle, the Na,K-ATPase pumps 3 Na
+
 out of the cell and 2 
K
+
 into the cell, while hydrolyzing 1 ATP molecule. The Na
+
 and K
+
 gradients 
across the PM, generated by the Na,K-ATPase, are of vital importance for 
cellular function. These include transport of nutrients and neurotransmitters, 
maintenance of cellular excitability, cell volume stabilization and retention of the 
resting membrane potential. 
The Na,K-ATPase complex consists of three subunits: α, β and FXYD. 
1.7.1 Na,K-ATPase α– catalytic subunit 
In mammals, there are four known isoforms of the Na,K-ATPase α-subunit. 
Alpha 1 is ubiquitously expressed throughout all the cells in the body and is 
thought to be the “housekeeping” isoform that establishes the transmembrane 
Na
+
 and K
+
 gradients. Alpha 2 has a more restricted expression and is expressed 
together with α1 in glial cells, smooth muscle cells, cardiac myocytes, and 
adipocytes. Several studies also indicate that α2 is expressed in neurons. During 
development, using immunohistochemistry and in situ mRNA hybridization, α2 
was shown to be expressed in neurons throughout the brain (Moseley, Lieske et 
al. 2003). During maturation, the expression of α2 becomes limited to glial cells 
and a few types of neurons, for example to the neurons of the respiratory center 
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(Ikeda, Onimaru et al. 2004). Alpha 3 is predominantly neuronal with some also 
expressed in the ovaries, while α4 is only expressed in male gonadal tissues. 
Alpha 1 – 3 share great amino acid homology (in humans there is 87 % 
homology and in rodents 86 %), but this is less so with α4. In spite of sharing 
more than 80 % amino acid homology, α1, α2 and α3 are different with regards 
to their ligand-binding affinities (see Table 1). Neurons express both α1 and α3, 
which is essential for recovery of the [Na
+
]i following neuronal activity (Azarias, 
Kruusmagi et al. 2012). Yet glial cells express both α1 and α2, which may be 
associated with pulsatile [Na
+
]i changes occurring in astrocytes during Na
+
-
coupled glutamate uptake. The catalytic α subunit consists of 10 transmembrane 
domains (TM). Three major cytosolic domains are recognized: the actuator 
domain, the nucleotide binding domain and the phosphorylation domain. The 
actuator domain includes the NH
2+
 cytosolic terminus (NT) and the second 
cytoplasmic domain (CD2) connecting TM2 and TM3. 
 
Table 1. Na,K-ATPase ligand binding 
 Km(Na+) mM Km(K+) mM Km(ATP) mM IC50, ouabain nM 
Alpha 1 12 0.83 3.5 48000 
Alpha 2 22 0.79 3.3 58.5 
Alpha 3 33 0.55 7.8 6.7 
Data reviewed from following papers (Jewell and Lingrel 1991; Munzer, Daly et al. 1994; 
O'Brien, Lingrel et al. 1994; Zahler, Zhang et al. 1997) 
 
Genetic knock-out homozygous mutants of the α1, α2 or α3 subunits, 
respectively, die in early embryonic development or at birth (James, Grupp et al. 
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1999; Barcroft, Moseley et al. 2004; Ikeda, Onimaru et al. 2004). While 
heterozygous α1 knock-out animals have been found to have increased 
locomotor response to methamphetamine and increased corticosterone in plasma 
(Moseley, Williams et al. 2007). Heterozygous α2 animals were reported to have 
increased anxiety, reduced spatial learning ability and late onset obesity 
(Kawakami, Onaka et al. 2005; Moseley, Williams et al. 2007). Heterozygous α3 
mice have decreased spatial learning, and increased locomotor activity (Moseley, 
Williams et al. 2007). 
1.7.2 Na,K-ATPase β subunit – chaperon protein and activity modulator 
There are three isoforms of the β subunit. The β subunits show great diversity in 
amino acid sequence. The homology between the human beta subunits is about 
35 %. The activity of the α catalytic subunit was shown to be differently 
modulated by the different β subunit isoforms, probably because the β subunit is 
important for occlusion of the K
+
 ions (Morth, Pedersen et al. 2007). The β 
subunit also plays a major role in targeting the Na,K-ATPase to the PM, hence 
tightly regulating expression levels of the catalytic α subunit (Ackermann and 
Geering 1990; McDonough, Geering et al. 1990; Geering 2001). In the Xenopus 
oocytes expression system, all β subunit isoforms could bind to all isoforms of α 
subunit in a ratio 1:1 (Crambert, Hasler et al. 2000). However, co-
immunoprecipitation studies showed that binding specificity was greater 
between α1 and β1 and between α2 and β2, respectively (Tokhtaeva, Clifford et 
al. 2012). The α and β subunits assemble readily in the ER via the help of the 
chaperone immunoglobulin binding protein BiP (Beggah, Mathews et al. 1996). 
Thus any misfolded α catalytic subunits cannot leave the ER. In the absence of 
the β subunit the α subunit interacts with β-COP, which also will result in 
retention of α in the ER (Morton, Farr et al. 2010). 
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1.7.3 Na,K-ATPase FXYD subunit – regulator of activity 
In mammals there are 7 FXYD subunits. These subunits are rather small 
transmembrane proteins, most of which consist of only one transmembrane 
domain. The different isoforms of FXYD have tissue-specific expressions. They 
are not necessary for the catalytic function of Na,K-ATPase, but can modulate 
the enzyme by changing its binding affinities for ligands (for review see Geering 
2006). 
 
The tissue-specific and developmental expression patterns of the different α, β, 
and FXYD isoforms may regulate the activity of the Na,K-ATPase, supporting 
Na
+
 and K
+
 transmembrane gradients and thus cellular functions via ion 
homeostasis, co-transport, excitability and other functions. 
1.7.4 Na,K-ATPase interactions 
Na,K-ATPase is known to interact with numerous proteins in the PM, the 
sarcoplasmic reticulum, the Golgi, and caveolar - all allowing for regulated PM 
targeting and Na,K-ATPase function (Wang, Haas et al. 2004; Alves, Farr et al. 
2010; Reinhard, Tidow et al. 2013). 
Several functional transporting protein domains have been described for Na,K-
ATPase α2, signifying the role of this subunit in influencing the function of 
transporters via alterations in the local ion balance. For example, a series of 
works describe a transporting protein complex consisting of the Na,K-ATPase 
α2 and the Na+, Ca2+ exchanger (NCX) in cardiac myocytes, skeletal muscle and 
astrocytes (Juhaszova and Blaustein 1997; Lencesova, O'Neill et al. 2004). This 
protein complex was proposed to overlay the endoplasmic reticulum (ER) with 
its sarcoendoplasmic reticulum Ca
2+
-ATPase pump (SERCA). Changes in α2 
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activity alter local Na
+
 concentration and influence local Ca
+
 concentration via 
the NCX exchanger, which may trigger calcium dependent signaling and global 
calcium events (Golovina, Song et al. 2003). The diffusion-limited spaces 
between the PM and the ER may be small and may be a significant co-factor in 
regulating Na
+
 and Ca
2+
 concentrations and thus the Na,K-ATPase α2, NCX and 
SERCA transporting protein complexes. 
Also, interaction between the Na,K-ATPase α2 and the neuron-specific K+ and 
Cl
-
 co-transporter KCC2 was shown in neurons in the brainstem respiratory 
center (Ikeda, Onimaru et al. 2004). In this complex, α2 was proposed to 
influence the local K
+
 gradient around the KCC2 transporter, thus supporting the 
extrusion of Cl
-
 from the cytosol of neurons. This transporting protein domain 
function may be crucial for generating the breathing rhythm. 
In neurons, the Na,K-ATPase enzyme was shown to interact with the scaffolding 
protein PSD-95 via its NH2-terminus (NT) (Blom, Ronnlund et al. 2011). PSD-
95 is one of the main organizer proteins in the synapse, interacting with multiple 
receptors and ion channels in the postsynaptic membrane. 
By interacting with IP3R, Na,K-ATPase is believed to trigger signaling cascades 
in the cell, among others leading to anti-apoptotic signaling (Zhang, Malmersjo 
et al. 2006; Liu, Spicarova et al. 2008; Liu and Xie 2010; Aperia 2012). 
1.7.5 Na,K-ATPase mutations 
Several mutations in Na,K-ATPase genes has been shown to be associated with 
neurological diseases. Mutations in the gene coding Na,K-ATPase α2 are 
associated with familial hemiplegic migraine type 2 (FHM2) (Bottger, Doganli 
et al. 2012). Mutations in Na,K-ATPase α3 are associated with rapid-onset 
dystonia parkinsonism (Bottger, Doganli et al. 2012), alternating hemiplegia of 
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childhood and CAPOS syndrome (cerebellar ataxia, areflexia, pes cavus, optic 
atrophy and sensorineural hearing loss) (Demos, van Karnebeek et al. 2014). 
Some of the mutations in Na,K-ATPase has been found to lead to a decrease in 
Na,K-ATPase α activity or inability to be expressed in the PM. For many of the 
mutations the biochemical consequences are yet unknown. There is no known 
disease associated to mutations in the Na,K-ATPase α1 isoform, probably due to 
its ubiquitous expression and vital importance for viability of any cell.  
1.8 GLUTAMATE TRANSPORTERS 
1.8.1 Glutamate transporter isoforms and expression 
Upon excitatory neuronal activity neurons release the neurotransmitter glutamate 
into the synaptic cleft, where its concentration can rise from 25 nM up to 1 mM 
(Dzubay and Jahr 1999; Herman and Jahr 2007). Glutamate has to be rapidly 
removed from the extracellular space, mainly by uptake into surrounding 
astrocytes to avoid excitotoxicity (Rothstein, Dykes-Hoberg et al. 1996). Upon 
this uptake the [Na
+
]i concentration in the astrocyte will rapidly increase, as 
glutamate is co-transported with Na
+
, which in turn will activate the Na,K-
ATPase. 
To date five excitatory amino acid transporters (EAAT) are discovered. EAAT3, 
EAAT4, EAAT5 are expressed mainly in neurons and EAAT1 and EAAT2 in 
glial cells (corresponding to GLAST and GLT-1 in rodents). The expression of 
glial glutamate transporters is developmentally and brain region specifically 
regulated (Regan, Huang et al. 2007) Further, the expression is upregulated in 
cell cultures in the presence of neurons and neuron-released factors (Chaudhry, 
Lehre et al. 1995; Swanson, Liu et al. 1997; Perego, Vanoni et al. 2000; Yang, 
Gozen et al. 2009). Recent findings also indicate that neuronal activity influences 
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the expression density and the subcellular localization of glutamate transporters 
in the PM (Benediktsson, Marrs et al. 2012). In astrocytes glutamate transporters 
are targeted to the sites adjacent to neurons (Chaudhry, Lehre et al. 1995) and, 
specifically, cluster opposing synapsin-1 positive synapses (Benediktsson, Marrs 
et al. 2012). 
Each glutamate is co-transported with 3 Na
+
 ions and one H
+
 ion and counter-
transported with one K
+
 ion (Levy, Warr et al. 1998; Owe, Marcaggi et al. 2006). 
Astrocytes respond with a large [Na
+
]i increase during glutamate uptake, which 
is especially pronounced in the astrocyte processes (Langer and Rose 2009), 
indicating site-specific expression of glutamate transporters. This [Na
+
]i signal 
may be a key to enhanced metabolism in the astrocyte following excitatory 
neuronal activity (Bernardinelli, Magistretti et al. 2004).  
The direction of transport depends on the ligands concentrations as well as the 
MP (Szatkowski, Barbour et al. 1990; Billups and Attwell 1996). Thus glutamate 
transport may also have a reversed direction and transport glutamate out of the 
cell, if K
+
 and Na
+
 transmembrane concentration gradients change significantly, 
as may be the case in severe pathological conditions such as ischaemia (for 
review see Grewer, Gameiro et al. 2008). Reversal of the glutamate transporter 
direction is believed to contribute to the neuronal excitotoxicity by excessive 
release of glutamate into the extracellular space (Rothstein, Dykes-Hoberg et al. 
1996; Rossi, Brady et al. 2007). 
1.8.2 Glutamate transporters in disease 
Excitotoxicity in the brain, resulting from excessive extracellular glutamate 
concentration contributes largely to neuronal degeneration. One of the suggested 
pathways for neurodegeneration, would be activation of glutamate receptor 
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NMDA on the neuron PM, and intracellular Ca
2+
 overload; and increase in NO 
and ROS, depolarization of mitochondrial membrane and decrease in ATP 
production (Yamagata, Andreasson et al. 1993; Bezzi, Carmignoto et al. 1998; 
Pepicelli, Fedele et al. 2002; Gu, Nakamura et al. 2010). Reduced expression or 
function of glutamate transporters is observed in several neurodegenerative 
conditions, such as ALS, AD, PD and Huntington’s (for review see Seifert, 
Schilling et al. 2006; Foran and Trotti 2009; Estrada-Sanchez and Rebec 2012). 
Knock-down of the glial GLT-1 transporter in a mouse model results in elevated 
extracellular glutamate levels, spontaneous seizures, neurodegeneration and 
progressive paralysis (Tanaka, Watase et al. 1997). 
1.8.3 Glutamate transporter interactions 
In the PM the glutamate transporters are assembled into trimers, with three 
independent binding sites for glutamate. The glial glutamate transporters have 
been shown to interact with Na,K-ATPase (this thesis Paper II and Rose, Koo et 
al. 2009; Genda, Jackson et al. 2011). As mentioned above, the Na,K-ATPase 
establishes the required transmembrane Na
+
 gradient for Na
+
-coupled transport. 
It may be speculated that the expression of Na,K-ATPase isoform with relatively 
low Na
+
 affinity is beneficial to govern the local [Na
+
]i in the same transporting 
protein domain as the glutamate transporter. Several scaffolding proteins, e.g. 
NHERF-2, GFAP, Sept2, are known to interact with the C-terminal (CT) of the 
glial glutamate transporters to stabilize it in the PM and by this they may have a 
regulatory role upon glutamate uptake (Kinoshita, Kimura et al. 2004; Sullivan, 
Lee et al. 2007; Ritter, Asay et al. 2011) 
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1.9 FAMILIAL HEMIPLEGIC MIGRAINE 
1.9.1 Familial Hemiplegic Migraine overview 
Familial Hemiplegic Migraine (FHM) is a subtype of migraines inherited by an 
autosomal dominant mode. The first attacks occur in the first and second decade 
of life and are generally triggered by emotional stress, physical exertion or head 
trauma (Jurkat-Rott, Freilinger et al. 2004). The attacks are often associated with 
motor weakness (hemiplegic) and can be accompanied by aura – visual, motor 
and auditory disturbances. Aura is thought to arise from cortical spreading 
depression - a wave of neuronal and glial cells depolarization (Lauritzen, Dreier 
et al. 2011). The aura may last for 20 min, after which the headache occurs and 
may last for up to 72 h. 
In some migraine patients severe conditions such as coma and cerebral edema, 
cerebellar ataxia, epilepsy and mental retardation have been described (Jurkat-
Rott, Freilinger et al. 2004; Spadaro, Ursu et al. 2004; Vanmolkot, Stroink et al. 
2006; Deprez, Weckhuysen et al. 2008). 
Several genes are linked to the FHM: CACNA1A, which codes for the neuronal 
voltage gated Ca
2+
 channel CaV2.1 (leading to FHM type 1), ATP1A2, which 
codes for Na,K-ATPase α2 (leading to FHM type 2), and SCN1A, which codes 
for the neuronal voltage gated Na
+
 channel Nav1.1 (leading to FHM type 3) (for 
review see Russell and Ducros 2011). 
1.9.2 Molecular mechanisms for the Familial Hemiplegic Migraine type 2 
FHM2 has been linked to more than 65 mutations in ATP1A2, the gene encoding 
Na,K-ATPase α2. These mutations are spread over the whole Na,K-ATPase 
molecule. The molecular mechanisms leading to FHM2 have not yet been 
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identified. It has been proposed that mutations in the Na,K-ATPase α2 subunit 
result in increased concentrations of extracellular glutamate and/or K
+
, making 
the brain more susceptible to cortical spreading depression (Segall, Mezzetti et 
al. 2005; Russell and Ducros 2011). Bente Vilsen’s group has extensively 
studied 9 different Na,K-ATPase α2 mutations and their affinities for external K+ 
(Schack, Holm et al. 2012). Eight out of the 9 mutants showed higher affinities 
for K
+
 than the wild type Na,K-ATPase α2 enzyme. All the mutants displayed a 
reduced turnover rate at saturating K
+
 and Na
+
 concentrations, suggesting that in 
a situation of cellular stress (i.e. epilepsy in which extracellular K
+
 is high), 
FHM2 mutants may have reduced Na,K-ATPase activity. These findings 
correlate well with the onset of the FHM2 attack when overexcitation is followed 
by depolarization of neurons and glial cells. 
One of the first FHM2 families described carried a Na,K-ATPase α2 missense 
mutation in the third transmembrane domain - G301R (Spadaro, Ursu et al. 
2004). Patients’ symptoms included hemiplegic migraine, seizures, prolonged 
coma, elevated temperature, sensory deficits, and transient or permanent 
cerebellar signs, such as ataxia, nystagmus, and dysarthria. Our collaborators in 
Århus, Denmark, designed a knock-in mouse model carrying the Na,K-ATPase 
α2 G301R mutation. We have used this model to test whether the Na,K-ATPase 
α2 FHM2 mutation displays alterations in cellular glutamate uptake. A reduced 
glutamate uptake may be predicted to increase the ambient glutamate 
concentration and thus contribute to neuronal overexcitation. 
1.10 AQUAPORIN 4 
1.10.1 Aquaporin 4 isoforms and expression 
Aquaporins (AQPs) are PM protein channels permeable to water according to 
the transmembrane osmotic gradient. AQP4 is expressed in CNS, lung, kidney, 
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gastrointestinal system, skeletal muscle, salivary glands, adrenals, anterior 
pituitary, prostate and seminal vesicles (Mobasheri, Marples et al. 2007). In the 
brain AQP4 is expressed mainly in astrocytes (Nielsen, Nagelhus et al. 1997), 
but also in other type of glia, such as reactive microglia (Tomas-Camardiel, 
Venero et al. 2004). AQP4 has two main protein isomers which differ with 
regards to 23 amino acids at the NT and named according to their starting 
methionine: M1 and M23 AQP4 isoforms. In the PM AQP4 assembles into 
heterotetramers consisting of the M1 and/or M23 isoforms. An increased ratio of 
the M23 isoform promotes the formation of large orthogonal arrays from the 
tetramers (Furman, Gorelick-Feldman et al. 2003). The AQP4 amino acids V24, 
A25 and F26 located in NT, are responsible for the formation of large orthogonal 
arrays, by providing interactions between the tetramers, while the NT of the M1 
isoform disrupts the orthogonal array formation (Suzuki, Nishikawa et al. 2008; 
Crane and Verkman 2009). It has also been observed that the M1 isoform 
surrounds the core of M23 built orthogonal arrays (Rossi, Moritz et al. 2012). In 
astrocytes the large orthogonal arrays are often found in the perivascular endfeet 
of the astrocyte PM (Nielsen, Nagelhus et al. 1997; Rash, Yasumura et al. 1998) 
and are thought to be important for water balance at the blood-brain barrier.  
The water permeability of aquaporins can be dynamically regulated by 
exogenous and endogenous factors via mechanisms involving intracellular 
signaling and probably protein phosphorylation (for review see Gunnarson, 
Zelenina et al. 2004; Zelenina 2010). Astrocyte AQP4 water permeability has 
been found to be dynamically regulated by glutamate and K
+
 (Gunnarson, 
Zelenina et al. 2008; Gunnarson, Song et al. 2009; Song and Gunnarson 2012). 
Reduced astrocyte AQP4 expression has an expected effect of reduced 
transmembrane water permeability (Solenov, Watanabe et al. 2004), but studies 
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have also reported delayed K
+
 and glutamate clearance (Binder, Yao et al. 2006; 
Zeng, Sun et al. 2007), enlarged extracellular space (Yao, Hrabetova et al. 2008), 
increased water content in the brain (Haj-Yasein, Vindedal et al. 2011), 
increased coupling between the astrocytes (Strohschein, Huttmann et al. 2011) as 
well as changes in synaptic plasticity, impaired hearing and smell (for review see 
Papadopoulos and Verkman 2013). Altered PM water permeability will likely 
influence neurotransmitter and ion homeostasis, which may lead to the described 
pathologies. Compensatory mechanisms may however facilitate molecular 
diffusion by increased astrocyte syncytium connectivity and enlarged 
extracellular space. 
Nevertheless, AQPs are not the only channels that can permeate water through 
the PM. In fact, most transmembrane transport is accompanied by water 
molecules, and each ion transported can be surrounded by around 120-180 
molecules of water. The glutamate transporter, has been shown to increase its 
permeability for water by 40 % during glutamate treatment (MacAulay, Gether 
et al. 2002), which could be one of contributors to astrocyte swelling observed 
during glutamate uptake. 
1.10.2 AQP4 in disease 
Many studies have focused on the role of astrocyte AQP4 in brain edema and 
brain injury. During brain edema AQP4 seems to play opposing roles, as it 
facilitates astrocyte swelling and cytotoxic brain edema formation, but may also 
be important in the resolution of brain edema and reduce swelling in the brain 
parenchyma (for review see Papadopoulos and Verkman 2007). AQP4 is known 
to be the target in the neurological disease neuromyelitis optica, an autoimmune 
disorder which affects the optic nerve and spinal cord, leading to edema and 
inflammation, myelin loss and neurodegeneration (for review see Saadoun and 
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Papadopoulos 2010; Ratelade and Verkman 2012). In a few pathological 
conditions the expression and polarity of AQP4 in astrocytes is altered. In an 
ALS model decreased expression of AQP4 and increased expression of Kir4.1 in 
astrocytes of SOD1
G93A
 mice was detected, which may alter K
+
 homeostasis and 
lead to neurodegeneration (Bataveljic, Nikolic et al. 2012). For glioma – an 
aggressive tumor, loss of cell polarization is accompanied by AQP4 orthogonal 
arrays degradation and AQP4 tetramers re-distribution (Neuhaus 1990). 
Interestingly, glioma cells often express both AQP4 and AQP1. Their expression 
is thought to enhance glioma migration (McCoy, Haas et al. 2010). 
1.11 METABOTROPIC GLUTAMATE RECEPTORS GROUP I 
During neuronal activity, several astrocyte G-protein coupled receptors are 
activated: metabotropic glutamate receptors (mGluRs), purinergic and adenosine 
receptors, GABAB receptors, which trigger signaling events to modulate 
astrocyte function (Kang, Jiang et al. 1998; Wang, Lou et al. 2006; Cunha 2008). 
Here I will focus on the group I mGluRs receptors – mGluR1 and mGluR5, and 
their known regulatory function in astrocytes. Group I mGluRs are a Gαq/11 
bound receptors and their signaling cascade includes PLC activation and IP3R 
mediated Ca
2+
 signaling cascades as well as activation of PKC via diacyl-
glycerol and phosphorylation of downstream protein targets. The signaling 
cascades started by group I mGluRs activation have well described long-term 
effects in neurons, regulating mRNA transcription and thus synaptic plasticity. 
Increasing data implicate group I mGluRs in the regulation of astrocyte function 
and in the cross-talk between astrocytes and neurons. Activation of group I 
mGluRs in astrocytes in a hippocampal slice preparation enhances astrocyte K
+
 
and glutamate uptake within minutes via a PKC dependent pathway (Devaraju, 
Fiacco 2013). Glutamate uptake is also acutely upregulated in reactive 
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astrocytes, mediated by mGluR5 activation (Vermeiren, Najimi et al. 2005). 
AQP4 water permeability is increased in primary astrocytes and hippocampal 
slice preparation upon group I mGluRs agonist treatment (Gunnarson, Zelenina 
et al. 2008). Group I mGluR induced Ca
2+
 responses in astrocytes were found to 
be increased in relation to decreased neuronal activity, while increased neuronal 
firing rates depressed mGluR-triggered Ca
2+
 signaling (Xie, Sun et al. 2012). 
One can speculate that astrocyte group I mGluRs can modulate several astrocyte 
functions and that its signaling is finely tuned in response to changes in neuronal 
activity. 
The scaffold associated proteins for anchoring of the mGluR5 in neurons are 
well explored; among them are Homer, NHERF2, Shank and syntaxin (for 
review see Hall and Lefkowitz 2002). Whether similar scaffolding proteins also 
anchor mGluRs in the astrocyte PM remains to be identified. Via scaffolding 
proteins mGluRs may be linked to functional protein complexes, allowing for 
rapid, local signaling events involving phosphorylation and Ca
2+
 modulating 
events.  
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2 METHODOLOGICAL CONSIDERATIONS 
2.1 ETHICAL APPROVAL 
Animal care and experimental procedures were conducted in accordance with 
Swedish animal protection legislation and experimental protocols approved by 
the Northern Stockholm Laboratory Animal Review Board. 
2.2 PRIMARY ASTROCYTE AND NEURON CELL CULTURES 
In this thesis astrocyte enriched culture or mixed astrocyte-neuron primary 
culture derived from either striatum or hippocampus was used. The selection for 
culture with either astrocytes enriched culture or astrocyte and neurons mixed 
culture was achieved with growth medium. It has become clear that astrocytes 
are most developed morphologically and functionally in the presence of neurons 
or neuron conditioned medium, see for example Paper III Fig. 2. To date the 
majority of astrocyte primary culture studies are performed on cultures where 
neurons were deliberately eliminated, leaving the astrocytes without their 
functional counterparts – neurons. With advancing imaging technologies and 
increased number of astrocyte and neuronal markers it is of benefit to study 
differentiated astrocytes function in the environment with neurons or neuron 
conditioned medium. 
For the Paper II neuron conditioned medium (NCM) was applied to astrocyte 
culture to achieve higher differentiation of astrocytes. Their morphology 
changed into cells with longer processes. In agreement with previously published 
studies NCM addition for 24 h had increased the expression of glutamate 
transporter GLAST (Drejer, Meier et al. 1983; Schlag, Vondrasek et al. 1998; 
Figiel and Engele 2000). The NCM addition had no effect on the expression of 
Na,K-ATPase. It has been proposed that Na,K-ATPase α2 is upregulated in glial 
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cell in presence of neurons (Knapp, Itkis et al. 2000). I didn’t observe any 
change in expression of either α1 or α2 after addition of NCM for 24-48 h. 
Possibly, the up-regulation of α2 requires longer time or other factors. 
2.3 OVEREXPRESSION OF EXOGENOUS PROTEINS 
For all studies in this thesis an approach of exogenous protein overexpression 
was used to visualize and functionally study the proteins of interest. For the 
Paper II several fluorescently tagged Na,K-ATPase proteins were expressed. The 
fluorescent tag was placed at the NT of α subunits, to allow for unaltered α 
subunits targeting to the PM. The codons of the first 5 amino acids in the NT of 
the Na,K-ATPase were removed in the DNA construct, as these amino acids are 
cleaved in the posttranslational modifications in the cell (Feschenko and 
Sweadner 1995). The function of Na,K-ATPase α1 and α2 subunits in the 
dynamic regulation of [Na
+
]i was studied by overexpressing either α1 or α2 in 
primary astrocytes. Red fluorescent protein mCherry was co-expressed with 
either α1 or α2, however was not directly tagged to the α subunit. This ensured, 
that the α activity wasn’t biased by any tag, but allowed identification of the 
transfected cells by red fluorescent signal in the cytosol. In the field of view cells 
lacking mCherry signal were identified as non-transfected cells. Often, however 
the mCherry signal was dim, possibly because mCherry was placed after the 
Na,K-ATPase α sequence in the IRES plasmid which may have resulted in a 
weaker expression. 
2.4 PLASMA MEMBRANE PROTEIN CO-EXPRESSIONS 
In the second study (Paper II), co-expression of Na,K-ATPase α1 and α2 
isoforms with glutamate transporter GLAST was measured. Previous studies 
showed co-distribution of Na,K-ATPase α2 and glutamate transporter 
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predominantly in perisynaptic astrocyte processes using immunostaining and 
electron microscopy (Cholet, Pellerin et al. 2002). Here I used a different 
approach to study co-localization of Na,K-ATPase isoforms with GLAST, which 
does not rely on antibody staining specificity. I expressed Venus tagged α1 or α2 
together with mTurquoise-tagged GLAST in primary astrocyte culture from 
striatum. Overexpression of the protein of interest with a fluorescent tag allows 
for live cell imaging and avoidance of unspecific antibody staining as well as 
preservation of cell morphology. However, it places other questions, for 
instance, the relevance of overexpression versus endogenous protein expression 
levels. 
2.5 IMAGING OF INTRACELLULAR SODIUM 
Several fluorescent Na
+
-selective indicators are suitable for measurements of 
[Na
+
]i: Na
+
-binding benzofuran isophthalate (SBFI), CoronaGreen, CoronaRed, 
Asante Natrium. They functionally differ by their Kd for Na
+
, their ion 
selectivity, sensitivity to pH and temperature, the linear range of measurement, 
and quantum yield of the fluorescent indicator. All of these factors must be 
considered while choosing the appropriate [Na
+
]i measurement tool and 
performing the experiments. 
SBFI was developed in 1989 in the laboratory of professor Roger Tsien 
(Harootunian, Kao et al. 1989), it has since been widely used for measurement of 
[Na
+
]i concentration in various cell types. It is determined to have a high 
resolution fluorescence response to the [Na
+
]i concentrations at the range of 0-40 
mM (Fig. 1A), which is within the physiological astrocyte [Na
+
]i concentrations. 
The dissociation constant of SBFI for Na
+
 is 11.3 mM.  
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We chose SBFI over other Na
+
 indicators for its ratiometric properties. Upon 
Na
+
 binding the excitation of SBFI shifts to shorter wavelengths. It allows 
comparing emissions at both excitation wavelengths 340 nm and 380 nm and to 
calculate a ratio as an internal normalization control of fluorescent indicator 
leakage and bleaching, as well as minor focus changes. Also, we chose this 
indicator for suitable range of [Na
+
]i sensitivity and well established procedures 
for calibration in situ. Focus stability of recording is important for monitoring 
dynamic changes in [Na
+
]i and a ratiometric indicator is beneficial for increased 
stability of the measurements.  
 
 
Figure 1. Intracellular sodium concentration measurement using SBFI. A. Fluorescence 
intensity ratio 340/380 nm was fit (R2>0.95) into right rectangular hyperbola function (the 
formula insert). B. For SBFI fluorescence intensity measurement, regions of interest were 
selected for each cell in the field of the view. Region of interest was selected to avoid the nucleus 
as shown with color outline. 
 
To load the SBFI into the astrocytes, its acetoxymethyl ester modification (AM-
SBFI) was used, which allows for transmembrane transfer of Na
+
 indicator. One 
 26 
of the draw-backs with AM indicators is that though they are strongly loading in 
the soma of the astrocyte, they often have weaker loading in the astrocyte 
processes. Therefore the intracellular ion measurements using the acetoxymethyl 
ester SBFI (AM-SBFI) are mostly possible in the cell soma. To measure the 
[Na
+
]i in the astrocyte processes PM an impermeable Na
+
 indicator may be 
loaded with a patch pipette, filling also the distant processes and providing 
sufficient fluorescent intensity for measurement.  
New generation [Na
+
]i indicators have wider [Na
+
]i range and sensitivity as well 
as usually higher quantum yield, resulting in a better signal/noise ratio. For 
example, Asante NaTRIUM Green 2 with Kd(Na+)=20 mM, allows for linear 
[Na
+
]i changes in the range 0-60 mM. 
2.5.1 Cytosolic SBFI calibration 
SBFI calibration is best performed in situ, since this indicator is sensitive to its 
environment, such as pH and K
+
 concentration. Therefore in situ calibration was 
performed after each recording with 0, 5, 10, 15, 20, 40 and when necessary 90 
mM Na
+
 solutions plus ionophores and 2 mM ouabain. 
Several publications indicate linear change of SBFI fluorescence intensity in the 
0-50 mM [Na
+
]i range. In my recordings the calibration curve was better fit into 
a right rectangular hyperbola function: R = R0+ ((a*x)/(x+b)), where R0, a and b 
are coefficients obtained from the fit (adapted from Zahler, Zhang et al. 1997). 
[Na
+
]i was calculated by a formula [Na
+
]i = (R – a)/(b+a – R)*R0 (Fig. 1A). 
The calibration was performed for each recording, rather than using a master 
calibration curve, which allowed for better sensitivity of the assays. 
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2.6 OUABAIN: AN ISOFORM SPECIFIC INHIBITOR OF NA,K-
ATPASE 
Cardiotonic steroids (CTS), such as ouabain, are specific inhibitors of Na,K-
ATPase, binding to an extracellular pocket and blocking the pumping activity of 
the enzyme. Cardiotonic steroids extracted from plants have since long been 
used to treat congestive heart failure. In the human body also low amounts of 
several endogenous CTS are identified, for example marinobufagenin and 
digoxin, and there is growing evidence for their involvement in regulation of 
blood pressure, cell differentiation and apoptosis and other novel functions (for 
review see Bagrov, Shapiro et al. 2009). In rodents Na,K-ATPase α1 has 
relatively low affinity for ouabain, unlike in all other mammals, while α2 and α3 
have relatively high ouabain affinities, approximately 1000 fold greater than α1. 
The IC50 value for ouabain is 48 μM for rat α1 and 58 nM for rat α2 (O'Brien, 
Lingrel et al. 1994). Therefore, in several experimental setups using rodent 
primary cultures ouabain was used to selectively block α2 and to separate its 
function from total Na,K-ATPase pool. 
2.7 PROTEIN-PROTEIN INTERACTION ASSAYS 
To test for protein-protein interaction several biochemical and imaging assays 
can be employed. Several of these assays are used in this thesis: Co-IP (suitable 
for whole protein-protein interactions); Pull-down (suitable for defining the 
motif of interaction); FRET (suitable for in situ whole protein-protein 
interaction). There are other methods, that are not used in this thesis, such as 
Yeast two hybrid assay (suitable for large screenings for interaction partners in 
yeast libraries) or Co-IP combined with mass spectrometry analysis (suitable for 
protein-protein interaction screening), as well as surface plasmon resonance 
(suitable for characterizing interaction kinetics of direct protein-protein 
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interactions) All of these methods have their strong and weak sides, which will 
be discussed below. Thus it is important to use a combination of methods when 
identifying and characterizing a protein-protein interaction. 
2.7.1 Co-immunoprecipitation 
Co-immunoprecipitation (Co-IP) assay allows for full size protein-protein 
interactions to be tested for. The assay relies on specificity of antibody used for 
immunoprecipitation of protein of interest - “bait” protein. To control for 
specificity of antibody interaction a control assay is performed in the same 
conditions, but instead of primary IP antibody, an IgG antibody is used raised in 
the same species as the IP antibody. As protein source I used total rat brain lysate 
in a RIPA buffer with mild detergents, such as Na
+
-deoxycholate and Triton-X 
100. Mild detergents allowed for optimal PM solubility and preservation of 
protein structure, allowing for protein-protein interactions. A similar buffer was 
also used in the pull-down assays (see below). Using brain lysate as a protein 
source may allow for protein complexes to be pulled out including associated 
proteins, such as scaffolding proteins and other members of the complex. In this 
setup Co-IP cannot give an answer to whether the interaction is direct or indirect. 
The Co-IP is a useful tool when testing for a predicted protein-protein 
interaction. When a screening for unknown/novel interaction partners is done, 
then Co-IP may be followed up by mass spectrometry analysis of the Co-IP 
sample. 
2.7.2 Pull-down assay 
Pull-down assay allows further to characterize interaction between proteins and 
to map the interacting domains. In this assay whole “bait” proteins or protein 
parts are amplified in E.coli, purified and set on the beads to pull out interacting 
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proteins from total protein lysate. Since the “bait” protein is synthesized from a 
construct expressed in E.coli, it allows modifying “bait” protein sequence and 
deducing the potential binding site between the interacting partners. When total 
protein lysate is used as a source of interacting proteins, the interaction may also 
be mediated via other proteins, thus pulling out a whole complex. However, 
when the “bait” protein is purified and mixed with purified potential partner, the 
direct protein-protein interactions can be established. 
Often a 3D structure of a protein is important for mediating protein-protein 
interactions. If only part of protein was used as “bait”, the interaction should be 
confirmed by full-length protein interaction assays, such as Co-
Immunoprecipitation or in situ Förster resonance energy transfer (FRET).  
2.7.3 Förster resonance energy transfer 
One of the techniques used to study protein-protein interactions in a cell PM is 
FRET. This technique is based on a process by which one fluorophore (the 
donor) while excited can transfer energy, without emitting a photon, to its 
neighboring fluorophore (the acceptor) and bring it to the excited state to emit 
light. The donor emission and acceptor excitation spectra should overlap for the 
energy transfer to occur. Also, two fluorophores should be in a close proximity 
to each other (~10 nm) and the spatial orientation of the donor and acceptor 
against each other is important for the energy transfer to occur. For classical 
FRET, several controls and system preparations should be performed to control 
for biases to the accuracy of measurements. Unwanted direct excitation of the 
acceptor while exciting the donor and signal “bleed-through” of the emission 
spectra of donor into the emission spectra of the acceptor may give false positive 
results. To tackle these issues in this study we have used a modified FRET 
technique, acceptor photo bleaching FRET, which helped us resolve some of 
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these biases due to the internal normalization procedure. Upon recording the 
donor emission, the acceptor fluorescence is irreversibly photo bleached, which 
if FRET was present increases emission efficiency of donor. By this technique 
the bleed-through problem is partially managed. It also eliminates the need for 
pre-experimental calibrations of the donor and acceptor spectra. For our study of 
AQP4 and Na,K-ATPase expression in the PM we tagged AQP4 with Venus and 
Na,K-ATPase was stained with antibodies tagged with Cy3. 
2.8 CELLULAR GLUTAMATE UPTAKE 
To measure glutamate uptake in primary cultures Tritium labeled D-Aspartate 
(
3
H D-Asp) uptake was used. D-Asp is transported into the cell by the same 
EAAT/glutamate transporters as glutamate. To separate the uptake function from 
other glutamate triggered events in the cell the glutamate is commonly 
substituted with D-Asp. EAATs Km value for glutamate is around 50-100 μM, 
and is similar to the Km for D-Asp (Arriza, Fairman et al. 1994; Swanson, Liu et 
al. 1997). When relative comparisons are made between the groups, it is possible 
to use this indicator of glutamate uptake. To date the radioactively labeled D-Asp 
assay is probably one of the most sensitive ways to measure D-Asp uptake in a 
biochemical method. There are several FRET based indicators for measurement 
of extracellular glutamate concentrations (Hires, Zhu et al. 2008; Marvin, 
Borghuis et al. 2013). For intracellular glutamate there are yet no fluorescent 
indicators. 
2.9 PLASMA MEMBRANE WATER PERMEABILITY ASSAY 
For this thesis we have used live cell imaging recordings for PM water 
permeability measurements, previously established in our laboratory (Zelenina 
and Brismar 2000; Zelenina, Zelenin et al. 2002). This method is based on 
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imaging of a confocal cross-section of a cell filled with the fluorescent indicator 
– calcein. By quickly changing the extracellular solution osmolality from 300 
mOsm to 200 mOsm water enters the cells and dilutes the calcein and its 
fluorescence intensity decreases accordingly in the selected intracellular section 
of the cell. The initial rate of fluorescence decrease is proportional to the water 
permeability of the PM. Primary astrocytes have a high water permeability of 
their PM, due to the endogenous expression of AQP4.  
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3 AIMS OF THE THESIS 
The overall aim of this thesis was to investigate the molecular and functional 
protein-protein interactions of Na,K-ATPase in astrocytes. 
Specific aims: 
• To explore the interaction between the putative members of transporting 
protein domain in astrocytes: Na,K-ATPase, AQP4 and mGluR5 and to 
investigate its functional regulation in intact astrocytes. 
• To investigate the molecular and functional interactions between the 
Na,K-ATPase α subunits and glutamate transporters (GLT-1 and 
GLAST) in astrocytes and to characterize dynamic changes in [Na
+
]i in 
response to glutamate exposure. 
• To characterize glutamate uptake in astrocytes expressing mutant Na,K-
ATPase α2 - a model of familial hemiplegic migraine type 2. 
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4 SUMMARY, RESULTS AND BRIEF DISCUSSION 
In current work we identified several molecular and functional interaction 
partners for the Na,K-ATPase in astrocytes. Our findings indicate that the 
astrocyte Na,K-ATPase is implicated in functional complexes of importance for 
the brain function, including water, ion and glutamate homeostasis. The data 
support that the Na,K-ATPase can form macromolecular complexes that may 
function as transporting protein domains in astrocyte PM. 
4.1 PAPER I 
In the first study we tested for protein-protein interaction between the Na,K-
ATPase and AQP4. The rationale for the study was based on the previous studies 
indicating a supportive role of the AQP4 water channel in K
+
 homeostasis 
associated with neuronal activity (Amiry-Moghaddam, Williamson et al. 2003) 
and the important role of Na,K-ATPase in K
+
 uptake (D'Ambrosio, Gordon et al. 
2002). We hypothesized that protein interaction between the Na,K-ATPase and 
AQP4 may exist in the astrocyte PM, maintaining local osmotic balance during 
transmembrane K
+
 currents. 
4.1.1 AQP4 interacts with Na,K-ATPase via its NH2- cytosolic terminus 
The full-length AQP4 was found to co-immunoprecipitate with full-length Na,K-
ATPase α1 and mGluR5, a previously known regulator of AQP4 water 
permeability (Gunnarson, Zelenina et al. 2008). Using pull-down assays we 
identified the site of the AQP4 protein that interacts with the Na,K-ATPase α1 
subunit. We localized that the binding site between the AQP4 and the Na,K-
ATPase was in the NH2- cytosolic terminus (NT) of the AQP4 (Paper I Fig. 2). 
NT of AQP4 protein differs between the M1 and M23 isoforms of AQP4, 
however the critical amino acids for this interaction found to be in the common 
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part of the M1 and M23 isoforms. Similarly, the Na,K-ATPase α2 and the 
mGluR5 receptor were also found to interact with AQP4 NT. The findings 
suggest the existence of a common, intermediate scaffolding protein bound to the 
NT of AQP4, which mediates the assembly of this complex. To date however, 
no scaffolding proteins binding to the NT of AQP4 are identified. 
4.1.2 AQP4 interaction with Na,K-ATPase in situ 
To confirm that this interaction also occurs in situ, Föster resonance energy 
transfer (FRET) studies were performed. Full-length AQP4 tagged with the 
fluorescent protein Venus (FRET Donor) was overexpressed in primary 
astrocytes. Endogenous Na,K-ATPase was immunolabeled with antibodies 
tagged with fluorochrome Cy3 (FRET Acceptor). The FRET efficiency, as 
discussed in section 2, is detectable when donor and acceptor are within ˜10 nm 
distance. Mutagenesis studies directed to the identified key amino acids for 
interaction on AQP4 reduced the FRET efficiency by half, confirming the 
protein-protein interaction between AQP4 and Na,K-ATPase. Since the acceptor 
was tagged indirectly to Na,K-ATPase, via primary and secondary antibodies, 
this would imply that the actual interacting partners (AQP4 and Na,K-ATPase) 
could be further than 10 nm apart. It should be noted that we, by these methods, 
could not rule out the presence of an intermediate, scaffolding protein mediating 
this interaction. 
The full-length AQP4 subunit was found to co-immunoprecipitate with the full-
length Na,K-ATPase α1 and α2 and the mGluR5, but not with the GLT-1 
glutamate transporter. In the Paper II in this thesis the Na,K-ATPase and 
glutamate transporter GLT-1 were found to co-immunoprecipitate. This may 
indicate different protein compositions in the macromolecular complexes 
containing Na,K-ATPase, suggesting that AQP4 and GLT-1 may interact with 
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different pools of Na,K-ATPase in the PM. Functionally though, AQP4 and 
GLT-1 may still be linked in a macromolecular complex, as supported by the 
findings that GLT-1 expression was reduced upon exposure to antibodies in 
neuromyelitis optica targeting AQP4 (Hinson, Roemer et al. 2008) as well as the 
reduction of GLAST expression found in an AQP4 knock-out model (Zeng, Sun 
et al. 2007). 
4.1.3 Astrocyte transporting microdomain 
We proposed that the protein-protein complex with Na,K-ATPase, AQP4 and 
mGluR5 in astrocytes may be implicated in the recovery of extracellular K
+
 
concentrations following neuronal activity. The relative contributions of 
astrocyte K
+
 channels and transporters (Na,K-ATPase, Kir4.1, NKCC1, KCC) in 
the K
+
 uptake from the extrasynaptic space is currently still debated (for review 
see Macaulay and Zeuthen 2012). In physiological conditions the Na,K-ATPase 
may play the key role for the K
+
 inward currents, while the Kir4.1 regulates the 
basal extracellular K
+
 concentration (D'Ambrosio, Gordon et al. 2002). Findings 
in a recent paper support the importance of astrocyte Na,K-ATPase in the 
recovery of extracellular K
+
 (Larsen, Assentoft et al. 2014). During neuronal 
activity astrocytes will take up not only K
+
 but also neurotransmitters with co-
transported and counter-transported ions. During this transport osmotic 
imbalance may occur, for which purpose water flow through AQP4 would be 
beneficial. 
4.1.4 Regulation of Na,K-ATPase and AQP4 complex via mGluR5  
In the described macromolecular complex, the water flow via AQP4 
permeability may be regulated by glutamate via activation of the complex 
“partner” mGluR5. We found that short treatment with glutamate enhanced 
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AQP4 water permeability (Paper I Fig. 6A). This was in accordance with our 
previous finding that activation of group I mGluRs increase AQP4 water 
permeability in astrocytes, mediated by an intracellular signaling cascade and 
phosphorylation of AQP4 (Gunnarson, Zelenina et al. 2008). Interestingly, group 
I mGluRs activation has also been reported to enhance astrocyte glutamate and 
K
+
 uptake (Devaraju, Sun et al. 2013). While the increased glutamate uptake was 
attributed to PKC phosphorylation of glutamate transporter, the mechanism for 
the observed enhancement of K
+
 currents was unclear. We tested the short term 
effect of the group I mGluRs agonist DHPG on Na,K-ATPase activity, by 
measuring changes in [Na
+
]i (Paper I Fig. 6B). We observed no change in [Na
+
]i 
which may imply that group I mGluRs activation does not influence Na,K-
ATPase activity. Group I mGluRs mediated increase in AQP4 water 
permeability may also indirectly facilitate K
+
 uptake. The astrocyte transporting 
protein complex between the Na,K-ATPase, AQP4 and mGluR5 may serve 
efficient extracellular K
+
 homeostasis and its function may be enhanced during 
neuronal activity via mGluR5. 
4.2 PAPER II 
4.2.1 Na+-coupled glutamate uptake is dependent on α1 and α2 Na,K-
ATPase 
In the second study we investigated the role of Na,K-ATPase α1 and α2 in 
supporting astrocyte glutamate uptake. The α2 isoform only or α1+α2 were 
selectively inhibited by the use of isoform-specific ouabain concentrations. We 
then measured 
3
H D-Aspartate (
3
H D-Asp) uptake as an estimate for glutamate 
uptake in primary astrocytes. When the α2 isoform was selectively inhibited we 
observed a decrease in glutamate uptake that was almost equal in magnitude to 
the decrease found when both α1+α2 were inhibited: D-Asp uptake was 
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decreased by 23 % upon inhibition of α2 (using 1 μM ouabain for 15 min) and 
by 26 % upon inhibition of α1 and α2 together (using 2 mM ouabain for 15 min). 
These results indicated that the Na
+
-coupled D-Asp uptake was equally 
dependent on the activity of both α1 and α2 pumps in primary striatum astrocyte 
culture. In cortical primary astrocytes as well as in cortical gliosomes short-term 
ouabain treatment (10 nM – 1 μM) caused increase of D-Asp uptake (Rose, Koo 
et al. 2009; Matos, Augusto et al. 2013). Previous findings indicated that 
glutamate uptake can be short-term modulated via signaling through mGluR5a 
receptor in reactive cortical astrocytes, which appears to lead to a higher number 
of mainly GLT-1 in the PM (Vermeiren, Najimi et al. 2005). The mechanism of 
short-term regulation of astrocyte glutamate uptake may be different between 
different brain regions, which could explain why we didn’t observe this 
mechanism. 
4.2.2 Na,K-ATPase α2 inhibition causes moderate [Na+]i increase 
All Na
+
-coupled transport, such as glutamate uptake into astrocytes, is majorly 
dependent on the transmembrane Na
+
 gradient. We therefore proceeded to 
measure changes in [Na
+
]i upon α1 and α2 inhibition, respectively. Somewhat 
surprisingly, selective inhibition of α2 only caused a modest, 2 mM, increase in 
[Na
+
]i (Paper II Fig. 1C), which was disproportional to the decrease in glutamate 
uptake (23 %) caused by α2 inhibition. There exists a Na+ gradient between the 
soma and the astrocyte processes in response to synaptic stimulation (Langer and 
Rose 2009). The α2 subunit together with glutamate transporter can localize to 
astrocyte perisynaptic microdomains (Cholet, Pellerin et al. 2002) and may 
significantly contribute to Na
+
 homeostasis in astrocyte processes and leaflets. In 
the current study [Na
+
]i was measured in the astrocyte soma, due to limitations in 
the cell loading of the Na
+
 sensitive indicator AM-SBFI. Thus it is possible, that 
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[Na
+
]i actually was higher in the astrocytes processes. The somatic [Na
+
]i 
increase corresponds with the data obtained on cortical primary astrocyte 
cultures, where 500 nM ouabain treatment resulted in 2 mM [Na
+
]i increase 
(Golovina, Song et al. 2003). There could be also other explanation to the small 
increase in [Na
+
]i that we observed here. At rest, when basal astrocyte [Na
+
]i is 
around 10 mM, the Na,K-ATPase α2 will be operating at less than 10 % of its 
maximum rate (KmNa = 22 mM). Therefore it may have a modest contribution in 
the regulation of basal [Na
+
]i levels. 
4.2.3 Dynamic changes in [Na+]i upon glutamate treatment, effect of 
overexpression of α1 or α2 
We proceeded to study how α1 and α2 maintain [Na+]i homeostasis in astrocytes 
when exposed to glutamate. We recorded the changes in [Na
+
]i in primary 
astrocytes overexpressing either the α1 or the α2 subunit. This allowed us to 
study the relative importance of each endogenous isoform as a driving force for 
glutamate uptake. Extrasynaptic glutamate concentrations can reach 1 mM upon 
vesicular glutamate release from firing neurons (Dzubay and Jahr 1999). We 
choose to use glutamate concentration of 200 µM, to saturate glutamate 
transport, as the Km(glutamate) is around 50 μM for glutamate transporters 
(Swanson, Liu et al. 1997). Exposure to glutamate 200 µM caused a larger 
increase in [Na
+
]i in α1 than in α2 overexpressing cells and, as a consequence, 
the recovery time for [Na
+
]i was shorter in cells overexpressing α2 (Paper II Fig. 
3). The results suggest that α2 may be more efficient than α1 to rapidly restore a 
large transient increase in [Na
+
]i, which may be related to the relatively low Na
+
 
affinity of α2 (Km for [Na
+
]i is 12 mM for α1 and 22 mM for α2). Intracellular 
Na
+
 dynamics was also recorded during treatment with lower glutamate 
concentration of 50 µM. We observed similar tendencies in results for 50 µM as 
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also for 200 µM glutamate treatment, i.e. lower maximum [Na
+
]i increase and 
faster recovery for the α2 expressing astrocytes in comparison with the α1 
expressing astrocytes (Fig. 2A and 2B). 
The [Na
+
]i reaches a plateau after glutamate treatment (Paper II Fig. 3A and 
other studies Chatton, Marquet et al. 2000; Barat, Boisseau et al. 2012). The 
intracellular sodium plateau probably reflects that an equilibrium for Na
+
 uptake, 
mainly through glutamate transporters, and counteracting Na
+
 extrusion by the 
Na,K-ATPase is achieved. Astrocytes can, as we showed, successfully sustain 
large [Na
+
]i increase. The maximum top level, however, is lower for the α2, than 
the α1 expressing astrocytes, again probably due to a relatively low Na+ affinity 
for the α2 isoform. 
 
Figure 2. Transient changes in [Na
+
]i following glutamate treatment in astrocytes 
expressing predominantly the Na,K-ATPase α1 or α2 isoforms. A. Maximum [Na+]i after 5 
min exposure to glutamate 50 µM in α1 (white) and α2 (grey) expressing astrocytes (Mann-
Whitney U test, N=17, * P<0.05). B. Intracellular sodium concentration recovery after 
discontinuation of glutamate 50 µM treatment in α1 (white) and α2 (grey) expressing astrocytes 
(Mann-Whitney U test, N=17, * P<0.05). C. Maximum [Na+]i after exposure to glutamate 200 or 
50 µM in non-transfected astrocytes from the same field of view as α1 and α2 transfected cells - 
Nα1 and Nα2, respectively (One-way ANOVA, N=54-106, *** P<0.001). Data are presented as 
mean ± SEM. 
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The non-transfected cells from α1 and α2 transfected plates (Nα1 and Nα2 
correspondently) were also analyzed. Following glutamate treatment maximum 
[Na
+
]i was lower in Nα2 cells, than in Nα1 cells (Fig. 2C). It may be that some 
cells were connected via gap junctions so that the transfected phenotype 
influenced [Na
+
]i dynamics in neighboring cells. There may also have been more 
transfected cells in the optical field of view, when the expression of mCherry 
indicator was weak. 
4.2.4 Isoform specificity of Na,K-ATPase α interactions with glutamate 
transporters 
Molecular interactions between the Na,K-ATPase and glutamate transporter 
have been reported in a few studies using co-immunoprecipitation and 
immunoprecipitation of GLT-1 from rat cortex followed by liquid 
chromatography-coupled tandem mass spectrometry (Rose, Koo et al. 2009; 
Genda, Jackson et al. 2011). However, these studies report opposing results for 
Na,K-ATPase α subunit interaction specificity with the glutamate transporter. 
Genda and Jackson et al. found that in rat cortex GLT-1 immunoprecipitated 
with Na,K-ATPase α1, α3 and β1; but not α2 while Rose and Koo et al. showed 
in cerebellum co-immunoprecipitation of only α2 and α3 with glutamate 
transporters. We performed co-immunoprecipitation from the whole brain lysate 
and found interaction of glutamate transporters with both α1 and α2. It is 
possible that in different brain regions these interactions would appear 
differently and therefore may be region and isoform specific. 
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Figure 3. Na,K-ATPase α subunit CD2 domain was found to interact with both glial 
glutamate transporters – GLT-1 and GLAST. A. Schematic representation of Na,K-ATPase α 
subunit embedded into the PM; NT-, CD2, CD3 and -CT are selected domains used in pull-down 
assay. B. and D. The interaction between glutamate transporter and the CD2 α2 domain is 
stronger than the interaction with the CD2 domains of Na,K-ATPase α1 or α3. C. and E. Mean 
integrated densities for glutamate transporter immunostaining in GST pull-down assays of CD 
α1, CD α2 and CD α3, respectively, in percent of CD2 α2 staining density. (One-way ANOVA, 
N=3, * P<0.05). F. Homology alignment map between the CD2 domain of rat α1, α2 and α3 
isoforms. Alpha 1 and α2 share 90 % homology, α1 and α3 share 88 % homology, while α2 and 
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α3 share 92 % homology. Identical amino acids marked yellow; conservative – blue; similar – 
green; non-similar – no color. 
 
We continued to identify the binding domains for the glutamate transporter 
interaction with the Na,K-ATPase α subunits. Pull-down studies were performed 
using different parts of the Na,K-ATPase protein as “bait” to pull down Na,K-
ATPase interacting protein partners. The Na,K-ATPase molecule was screened 
for potential binding sites, selecting all large loops of the molecule for “bait” 
(Fig. 3A): NT, CD2, CD3, CT. We found interaction between both glutamate 
transporters GLAST and GLT-1 and the CD2 domain of all three Na,K-ATPase 
α subunits: α1, α2 and α3 (Paper II Fig. 4 and Fig. 3B, 3D). This is probably, at 
least partly, attributed to the high homology that exists in the CD2 domain 
between these isoforms (Fig. 3F). There appeared to be a stronger binding 
between the α2 and both glutamate transporters, compared to the α1 and α3. The 
reason for this is unclear, however it may imply that several protein interaction 
domains involved in the α2 CD2 interaction with glutamate transporters, which 
could explain stronger binding of α2 to the glutamate transporter. The exact 
amino acids involved in the protein interactions still remain to be identified. 
To evaluate the co-expression of Na,K-ATPase and the glutamate transporter 
GLAST in the PM we performed confocal imaging of co-expressed GLAST 
with either the α1 or the α2 subunit in primary astrocytes (Paper II Fig. 4I). Co-
localization of both α1 and α2 with GLAST was observed. Cultured primary 
astrocytes are less polarized than in the intact brain, since endothelial cells and 
synaptic contacts are reduced or absent. Immunogold studies have indicated that 
glutamate transporters are concentrated in astrocyte leaflets, adjacent to neuronal 
PM (Chaudhry, Lehre et al. 1995), and α2 has been found to be mainly localized 
in leaflets facing glutamatergic synapses (Cholet, Pellerin et al. 2002). It is 
  43 
possible that the interaction between the α2 and the glutamate transporters is 
relatively stronger than for the other α subunits, which in differentiated 
astrocytes in the brain may result in co-localization in the subcellular domains of 
leaflets facing glutamatergic synapses. The combined molecular and functional 
interactions between astrocyte α2 and the glutamate transporters, as shown in 
this thesis, may thus enable efficient regulation of [Na
+
]i during glutamate uptake 
following neuronal activity. 
4.3 PAPER III 
4.3.1 Glutamate uptake in primary cultures derived from hippocampus 
of FHM2 knock-in mouse model 
The molecular consequences of Na,K-ATPase α2 dysfunction in FHM2 are not 
well understood. Migraine attacks are usually preceded by a spreading wave of 
glial and neuronal depolarization, possibly caused by altered glutamate and/or K
+
 
uptake from the extracellular space (Leo, Gherardini et al. 2011). In this study D-
Asp uptake (as a measure of glutamate uptake) was measured in primary cultures 
derived from hippocampus of the FHM2 knock-in G301R mutant mouse model. 
Two culture types were used; either astrocyte enriched cultures or mixed cultures 
of astrocytes and neurons. D-Asp uptake was reduced in the mixed astrocyte-
neuron cultures derived from E17 G301R heterozygous (HEZ) (by 10 %) and 
homozygous (HOZ) (by 17 %) mouse brains as compared to WT (Paper III Fig. 
3D). Interestingly, in the astrocyte enriched cultures, no significant change in D-
Asp uptake was found between the genotypes (Paper III, Fig. 3C). It is difficult 
to ascertain the reasons for the difference between the two cultures. 
Immunolabeling against GFAP revealed morphological changes in astrocytes 
when co-cultured with neurons - the astrocytes were larger, with more extensive 
branching (Fig. 4). These astrocytes are possibly more differentiated, due to the 
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exposure to neuron-released factors as well as direct interactions with neurons in 
the mixed cultures. The absolute counts per minute of radioactively labeled 
3
H 
D-Asp, normalized to protein concentration, was 2.9 times higher in the 
astrocyte and neuron mixed cultures, than in the astrocyte enriched cultures. This 
could probably reflect a higher expression level of Na,K-ATPase α2 in 
astrocytes cultured in the presence of neurons (Paper III Fig. 3A and 3B), but 
also likely a higher number of glutamate transporters participating in the uptake. 
Higher CPM value, increases signal to noise ratio and therefore the sensitivity of 
the assay may be higher for the mixed culture in comparison with enriched 
culture. It is also plausible that the neuronal glutamate transporter (EAAT3) 
contributes to the changes observed, due to secondary effects of the Na,K-
ATPase α2 mutation on neuronal glutamate uptake. 
Inefficient glutamate uptake may lead to overexcitability in the brain (Seifert and 
Steinhauser 2013). Apart from neurotoxic events it may lead to excess of 
excitatory neuronal activity in different areas of the brain. For instance, Na,K-
ATPase α2 knock-out mice and W887R FHM2 mutant knock-in mice display 
greater anxiety levels than WT mice, which may be related to overexcitability in 
amygdala (Ikeda, Onaka et al. 2003; Leo, Gherardini et al. 2011). Na,K-ATPase 
α2 mutation may also result in insufficient K+ uptake and increased neuronal 
susceptibility to excitation. 
  45 
 
 46 
Figure 4. Astrocyte GFAP immunostaining. A. Astrocyte enriched culture GFAP 
immunolabeling. Scale bar 40 μm. B. Astrocyte neuron mixed culture GFAP immunolabeling. C. 
Boxplot diagram of astrocyte diameter in μm (median value, interquartile range and minimum 
and maximum values) in astrocyte enriched cultures (white) and astrocyte and neuron mixed 
cultures (grey) from WT, HEZ and HOZ G301R α2 mutant mice. Data collected from 2 
individual experiments. Number of astrocytes in each group N=40-60. 
4.3.2 Na,K-ATPase a2 G301R mutant plasma membrane expression 
In the G301R knock-in mouse we found significant downregulation of the Na,K-
ATPase α2 G301R in embryonic (E17) and in adult (P50) brain (Paper III, Fig. 
1). There are contradictory reports regarding the targeted expression of G301R in 
the PM. Santoro, Manganelli et al. reported biased expression of Na,K-ATPase 
α2 G301R mutant in the PM of transfected HeLa and HEK293 cells using 
imaging and biochemical techniques (Santoro, Manganelli et al. 2011). 
However, in Xenopus oocytes the Na,K-ATPase α2 G301R mutant was found to 
be normally targeted to the PM, but to have reduced activity (Tavraz, Durr et al. 
2009). Possibly the expression system used may influence the expression of 
Na,K-ATPase on the PM. We used rat astrocyte derived cell line and primary 
astrocyte mouse cultures to determine the PM expression of Na,K-ATPase α2 
(Fig. 5A and 5B). The expression of the Na,K-ATPase α2 G301R mutant was 
reduced in the PM in comparison to α2 WT, as shown by the fluorescence 
intensity distribution between the PM and cytosol using Venus-tagged α2 (Fig. 
5D and 5E). If the mutant G301R is not targeted to the PM at all there will be a 
difficulty to accurately identify the edge of the cell where the PM should be (Fig. 
5C), thus the reduction in the PM/cytosol ratio could be even greater. Reduced 
PM targeted expression of the mutant α2 could be due to incorrect folding of 
Na,K-ATPase G301R α2 and/or interaction with chaperone proteins, resulting in 
premature disruption of the protein. 
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Figure 5. Hindered plasma membrane expression of Na,K-ATPase α2 G301R mutant. A. 
Confocal live cell image of Na,K-ATPase α2 WT and G301R expression in astrocyte cell line. 
Insert shows distribution of signal across the section of a cell, which is indicated with dashed 
lines: α2 WT (green) or α2 G301R mutant (red). Scale bar 10 μm. B. Confocal live cell image of 
single primary astrocyte cell expressing either Na,K-ATPase α2 WT or G301R. Insert shows 
distribution of signal across the section of a cell, which is indicated with dashed lines: α2 WT 
(green) or α2 G301R mutant (red). C. Confocal live cell image of single cell expressing either 
Na,K-ATPase α2 WT or G301R. Regions of interest for each transfected cell were selected on a 
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border of the cell and adjacent region in the cytosol. D-E. Ratio of these signals was taken for 
normalization and is compared between α2 WT and G301R. 
 
Several FHM2 mutations were reported to have impaired PM expression: 
delK935-S940, S966 frame shift, P979L, W887R (Tavraz, Durr et al. 2009; Leo, 
Gherardini et al. 2011). The first knock-in mouse model generated for FHM2 
mutation was the W887R. The homozygous mice died just after birth, and 
heterozygous mice had decreased threshold for cortical spreading depression 
(Leo, Gherardini et al. 2011). Already in the embryonic brain (E19.5) the Na,K-
ATPase W887R mutant was downregulated to barely detectable level. In the 
HeLa expression system the W887R mutant was retained in the endoplasmic 
reticulum to a large extent. It is possible that the phenotype of the G301R knock-
in mouse model studied in this thesis, due to its altered expression in the PM, 
will be similar to the heterozygous W887R knock-in model and α2 heterozygous 
knock-out model. In conclusion, it may be that mutant Na,K-ATPase α2 may not 
express fully in the PM and instead of dysfunctional α2 in the PM may create an 
effect of haploinsufficiency, i.e. the absence of protein activity of one of two 
alleles. 
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4.4 GENERAL DISCUSSION 
In this thesis I explored astrocyte plasma membrane protein complexes with 
focus on the role of the Na,K-ATPase. Na,K-ATPase is a key enzyme for the cell 
viability and it is not surprising that its function is linked to the function of 
several other PM and intracellular proteins. Molecular interactions between 
functionally linked proteins are often beneficial for efficient and optimal activity 
of protein complexes. Through the work with this thesis it has become clear that 
Na,K-ATPase is participating in a variety of different protein complexes in the 
astrocyte PM also with regard to Na,K-ATPase catalytic subunit specificity. 
We have found a molecular link between the Na,K-ATPase and AQP4 in the 
astrocytes PM. We propose that this complex may be important for the water and 
K
+
 homeostasis. Moreover the complex was found to be short-term regulated by 
the group I mGluR via regulation of AQP4 increase in water permeability, which 
shows a potential to respond to neuronal activity. It may be beneficial for the 
astrocyte ion homeostasis during excessive K
+
 uptake, for which Na,K-ATPase 
is a key enzyme, to maintain osmotic balance by increased permeability of 
AQP4.  
Astrocytes, as few other cell types in the body express not only the ubiquitous 
Na,K-ATPase α1 subunit, but also a glia specific α2. Unlike cells with only the 
ubiquitous α1 subunit, astrocytes experience pulsatile changes in [Na+]i during 
excitatory activity of nearby neurons. The released neurotransmitter is 
effectively taken up by astrocytes via Na
+
-coupled transporters. We suggest that 
the uneven inward Na
+
 currents require for astrocytes to express an additional 
second Na,K-ATPase α subunit with relatively low apparent Na+ affinity to 
ensure efficient maintenance of [Na
+
]i during excessive [Na
+
]i load. Spatial 
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proximity of Na,K-ATPase to glutamate transporters may also be required to 
maintain basal [Na
+
]i and retain functional glutamate uptake. 
Rare genetic diseases, such as FHM2, give us insight into the molecular 
mechanisms of pathology and disease development. With the identification of 
several genetic mutations expressed in neurons and astrocytes it becomes more 
clear that the migraine types have a neurological component and are complex 
disorders involving several systems. Novel mutations discovered in Na,K-
ATPase α2 and the coupling to glutamate transporters and efficient glutamate 
uptake identifies new potential molecular drug targets for migraine treatment and 
gives better understanding of molecular mechanisms in disease processes. 
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